The Leukemia & Lymphoma Society (LLS) hears from blood cancer patients and caregivers each day about the profound effects of the pandemic on their cancer care and daily lives. While it’s been an 
incredibly trying time, there are bright spots ahead as we all celebrate FDA authorization of two COVID-19 vaccines and look toward more safe, effective vaccines on the horizon. While we may not have all the answers at this time, LLS Chief Medical Officer, Gwen Nichols, MD, is addressing a few FAQs from blood cancer patients and caregivers based on what we know right now. We encourage you to discuss COVID-19 vaccines with your oncologist and healthcare team.
It’s also critical for blood cancer patients and their caregivers to continue taking precautions such as wearing a mask, maintaining social distancing, and washing your hands frequently. Data continues to show that blood cancer patients are at higher risk of developing more severe illness from COVID-19.
As you continue to navigate your care during these challenging times. LLS offers a wide array of free education and support that can help. LLS Information Specialists – highly trained oncology professionals – are here to provide one-on-one support at (800) 955-4572 or by live chat/email here.
Last updated 1/8/2021 (Courtesy of LLS)
Click here for Frequently Asked Questions
Roswell Park Comprehensive Cancer Center – December 7, 2020
Covid-19 Vaccine – Frequently Asked Questions (the latest from the New England Journal of Medicine)
NCCN Shares New Guidance Principles for Vaccinating People with Cancer against COVID-19
(January 22, 2021 update)
This resource page will be updated regularly with the latest COVID-19 vaccine information.
